BioTelemetry Technology ApS: Financial statements 2021
CVR: 37552534
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BioTelemetry Technology ApS (CVR 37552534) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -157,465 and a net result of DKK -126,560 compared with DKK -1,137,196 the year before. Equity in the 2021 report amounted to DKK 15,182,715. The solvency ratio was 98.9%.
- Gross Profit
- DKK -157,465
- Profit/Loss
- DKK -126,560
- Equity
- DKK 15,182,715
- Total Assets
- DKK 15,352,130
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -157 t. | -127 t. | 15.2 mio. | - |
| 2020 | - | -124 t. | -1.1 mio. | 15.3 mio. | - |
| 2019 | - | 412 t. | 796 t. | 16.4 mio. | 0 |
| 2018 | - | -1 mio. | -698 t. | 15.7 mio. | 0 |
| 2017 | - | -2.5 mio. | -15.2 mio. | 16.3 mio. | - |
Official annual report
Find more companies like BioTelemetry Technology ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BioTelemetry Technology ApS has published its annual report for 2020. Gross profit came to DKK -124,455, and the net result was DKK -1,137,196.
As of June 30, 2021, Heather Carter Getz has stepped down as director of BioTelemetry Technology ApS.
As of June 30, 2021, Joseph Henry Capper has stepped down as director of BioTelemetry Technology ApS.
About BioTelemetry Technology ApS
BioTelemetry Technology ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2016. The company has been dissolved on 20 December 2023. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -115,998 and a net result of DKK -92,258 compared with DKK -126,560 the year before. Equity in the 2022 report amounted to DKK 15,090,457.